References
- The top 10 causes of death – World Health Organization. [cited 2019 Jan 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
- WHO. Global tuberculosis report 2020 – World Health Organization; [cited 2020 Oct 20]. Available from: https://www.who.int/tb/publications/global_report/en/.
- Reiner Z. Primary prevention of cardiovascular disease with statins in the elderly. Curr Atheroscler Rep. 2014;16(7):420.
- Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A. 2008;105(11):4376–4380.
- Miner MD, Chang JC, Pandey AK, et al. Role of cholesterol in Mycobacterium tuberculosis infection. Indian J Exp Biol. 2009;47(6):407–411.
- Gatfield J, Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science. 2000;288(5471):1647–1650.
- Russell DG, VanderVen BC, Lee W, et al. Mycobacterium tuberculosis wears what it eats. Cell Host Microbe. 2010;8(1):68–76.
- Wilburn KM, Fieweger RA, VanderVen BC. Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis. Pathog Dis. 2018;76(2). DOI:https://doi.org/10.1093/femspd/fty021
- Lai CC, Lee MT, Lee SH, et al. Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort. Thorax. 2016;71(7):646–651.
- Liao KF, Lin CL, Lai SW. Population-based case-control study assessing the association between statins use and pulmonary tuberculosis in Taiwan. Front Pharmacol. 2017;8:597.
- Su VY, Su WJ, Yen YF, et al. Statin use is associated with a lower risk of TB. Chest. 2017;152(3):598–606.
- Kim MC, Yun SC, Lee SO, et al. Association between tuberculosis, statin use, and diabetes: a propensity score-matched analysis. Am J Trop Med Hyg. 2019;101(2):350–356.
- Kang YA, Choi NK, Seong JM, et al. The effects of statin use on the development of tuberculosis among patients with diabetes mellitus. Int J Tuberculosis Lung Dis. 2014;18(6):717–724.
- Lee MY, Lin KD, Hsu WH, et al. Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes. Int J Mol Sci. 2015;16(5):11369–11384.
- Pan SW, Yen YF, Feng JY, et al. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: a population-based cohort study. Br J Clin Pharmacol. 2020;86(3):569–579.
- Magee MJ, Salindri AD, Kornfeld H, et al. Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins. Eur Respir J. 2019;53(3):1801695.
- Parihar SP, Guler R, Khutlang R, et al. Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. J Infect Dis. 2014;209(5):754–763.
- Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8(6):373–418.